📗 Cite This Artifact
European Neurodegeneration Epidemiology
European Neurodegeneration Epidemiology
Overview
Europe presents a unique epidemiological landscape for neurodegenerative diseases, characterized by:
- The world's highest proportion of elderly population (20%+ aged 65+)
- Significant variation across Western, Central, and Eastern Europe
- Well-developed healthcare systems enabling better ascertainment
- Strong research infrastructure (EUROPAD, EAN networks)
Alzheimer's Disease
Prevalence by Region (2025)
| Region | Prevalence (65+) | Total Cases | Notes |
|--------|-----------------|-------------|-------|
| Western Europe | 7-9% | ~5-6 million | Highest prevalence globally |
| Southern Europe | 6-8% | ~3-4 million | Italy, Spain, Portugal, Greece |
| Northern Europe | 5-7% | ~2-3 million | UK, Scandinavia, Netherlands |
| Central/Eastern Europe | 5-7% | ~3-4 million | Poland, Czech, Hungary, Romania |
| Total Europe | 6-8% | ~14-17 million | |
Prevalence by Country (2025)
| Country | Dementia Cases | % of Population | Notes |
|---------|----------------|----------------|-------|
| Germany | ~1.5 million | ~1.8% | Largest absolute burden |
| France | ~1.2 million | ~1.9% | Well-documented |
| Italy | ~1.1 million | ~1.8% | High longevity |
| United Kingdom | ~850,000 | ~1.3% | Underlying population size |
| Spain | ~800,000 | ~1.7% | Aging population |
| Poland | ~600,000 | ~1.5% | Growing rapidly |
| Netherlands | ~250,000 | ~1.5% | Excellent registry data |
| Sweden | ~200,000 | ~2.0% | Highest per capita |
| Belgium | ~200,000 | ~1.8% | |
| Austria | ~150,000 | ~1.7% | |
European Neurodegeneration Epidemiology
Overview
Europe presents a unique epidemiological landscape for neurodegenerative diseases, characterized by:
- The world's highest proportion of elderly population (20%+ aged 65+)
- Significant variation across Western, Central, and Eastern Europe
- Well-developed healthcare systems enabling better ascertainment
- Strong research infrastructure (EUROPAD, EAN networks)
Alzheimer's Disease
Prevalence by Region (2025)
| Region | Prevalence (65+) | Total Cases | Notes |
|--------|-----------------|-------------|-------|
| Western Europe | 7-9% | ~5-6 million | Highest prevalence globally |
| Southern Europe | 6-8% | ~3-4 million | Italy, Spain, Portugal, Greece |
| Northern Europe | 5-7% | ~2-3 million | UK, Scandinavia, Netherlands |
| Central/Eastern Europe | 5-7% | ~3-4 million | Poland, Czech, Hungary, Romania |
| Total Europe | 6-8% | ~14-17 million | |
Prevalence by Country (2025)
| Country | Dementia Cases | % of Population | Notes |
|---------|----------------|----------------|-------|
| Germany | ~1.5 million | ~1.8% | Largest absolute burden |
| France | ~1.2 million | ~1.9% | Well-documented |
| Italy | ~1.1 million | ~1.8% | High longevity |
| United Kingdom | ~850,000 | ~1.3% | Underlying population size |
| Spain | ~800,000 | ~1.7% | Aging population |
| Poland | ~600,000 | ~1.5% | Growing rapidly |
| Netherlands | ~250,000 | ~1.5% | Excellent registry data |
| Sweden | ~200,000 | ~2.0% | Highest per capita |
| Belgium | ~200,000 | ~1.8% | |
| Austria | ~150,000 | ~1.7% | |
Projections by Region
| Region | 2025 | 2030 | 2040 | 2050 |
|--------|------|------|------|------|
| Western Europe | 5.5M | 6.5M | 8M | 10M |
| Southern Europe | 3.5M | 4M | 5M | 6M |
| Northern Europe | 2.5M | 3M | 4M | 5M |
| Central/Eastern Europe | 3.5M | 4M | 5.5M | 7M |
| Total Europe | 15M | 17.5M | 22.5M | 28M |
Economic Burden
| Country | Annual Cost (EUR billions) | Per-Patient Cost |
|---------|---------------------------|------------------|
| Germany | ~€50 | ~€33,000 |
| France | ~€35 | ~€29,000 |
| UK | ~£30 (~$38B) | ~£35,000 |
| Italy | ~€25 | ~€23,000 |
| Spain | ~€18 | ~€22,000 |
| Total Europe | ~€200-250 billion | ~€25,000 |
Parkinson's Disease
Prevalence by Region (2025)
| Region | Prevalence | Total Cases | Notes |
|--------|------------|-------------|-------|
| Western Europe | 1-2% (65+) | ~1.5-2 million | Highest documentation |
| Southern Europe | 1-1.5% (65+) | ~0.8-1 million | |
| Northern Europe | 1-2% (65+) | ~0.6-0.8 million | |
| Central/Eastern Europe | 0.8-1.2% (65+) | ~0.8-1 million | |
| Total Europe | ~1.5% (65+) | ~4-5 million | |
Prevalence by Country (2025)
| Country | PD Cases | Notes |
|---------|----------|-------|
| Germany | ~400,000 | Largest in Europe |
| France | ~300,000 | |
| Italy | ~250,000 | |
| UK | ~200,000 | |
| Spain | ~150,000 | |
| Poland | ~120,000 | Growing |
| Netherlands | ~60,000 | Excellent data |
| Sweden | ~50,000 | High quality |
| Belgium | ~40,000 | |
| Austria | ~35,000 | |
Projections
| Year | Projected Prevalence |
|------|---------------------|
| 2025 | 4-5 million |
| 2030 | 5-6 million |
| 2040 | 7-8 million |
| 2050 | 9-10 million |
Amyotrophic Lateral Sclerosis (ALS)
European Prevalence (2025)
| Metric | Value |
|--------|-------|
| Total prevalence | ~30,000-40,000 |
| Annual incidence | ~1-2 per 100,000 |
| Annual deaths | ~15,000-20,000 |
| Median survival | 2-4 years |
Regional Distribution
- Northern Europe: Higher incidence (possibly better ascertainment)
- Mediterranean: Slightly lower rates
- Eastern Europe: Underdiagnosed
By Country
| Country | Estimated Cases |
|---------|----------------|
| Germany | ~8,000 |
| France | ~6,000 |
| UK | ~5,000 |
| Italy | ~4,000 |
| Spain | ~3,000 |
| Poland | ~2,000 |
Frontotemporal Dementia (FTD)
European Prevalence (2025)
| Metric | Estimated Value |
|--------|-----------------|
| Total cases | ~80,000-120,000 |
| Mean age at onset | 50-60 years |
| Underdiagnosis factor | 2-3x |
Genetic Profile:
- C9orf72 expansion: ~25% of familial cases
- GRN mutations: ~10-15%
- MAPT mutations: ~10%
Huntington's Disease
European Prevalence (2025)
| Metric | Estimated Value |
|--------|-----------------|
| Gene carriers | ~100,000-150,000 |
| Manifest patients | ~35,000-50,000 |
| Highest prevalence | UK, Ireland, Scandinavia |
Parkinson's Plus Syndromes
| Disorder | Estimated European Cases |
|----------|--------------------------|
| MSA | ~30,000-50,000 |
| PSP | ~50,000-70,000 |
| CBS | ~15,000-25,000 |
European Research Networks
- EAN (European Academy of Neurology): Parkinson's and dementia guidelines
- EUROPAD: Parkinson's disease registry
- DEMENTIA EURORE: Alzheimer's research consortium
- ALS/MND European Registry: Rare disease tracking
Policy Initiatives
- EU Brain Health Strategy: Coordinated research effort
- National Dementia Plans: Most EU countries have implemented
- Horizon Europe Brain Health: €1.5B research funding
Summary: European Burden
| Disease | Prevalence (2025) | Projected 2050 | Economic Cost |
|---------|-------------------|----------------|---------------|
| Alzheimer's Disease | 14-17 million | 28 million | ~€250 billion |
| Parkinson's Disease | 4-5 million | 10 million | ~€40 billion |
| ALS | 30,000-40,000 | Stable | ~€3 billion |
| FTD | 80,000-120,000 | 150,000+ | ~€10 billion |
| Huntington's | 35,000-50,000 | Stable | ~€2 billion |
Cross-Links
- [Neurodegeneration Impact Measures](/diseases/neurodegeneration-impact-measures)
- [European Academy of Neurology](/institutions/ean)
- [Epidemiology of Neurodegenerative Diseases](/diseases/epidemiology-neurodegenerative-diseases)
- [Alzheimer's Disease](/diseases/alzheimers-disease)
- [Parkinson's Disease](/diseases/parkinsons-disease)
References
▸Metadataorigin_type: v1_polymorphic_backfill
| slug | diseases-european-neurodegeneration-epidemiology |
| kg_node_id | None |
| entity_type | disease |
| origin_type | v1_polymorphic_backfill |
| source_table | wiki_pages |
| wiki_page_id | wp-287f3fa7cdca |
| __merged_from | {'merged_at': '2026-05-13', 'unprefixed_id': 'diseases-european-neurodegeneration-epidemiology'} |
| _schema_version | 1 |
No provenance edges found
Use ?embed=1 to load the artifact without SciDEX chrome — suitable for iframing into wiki pages or external sites.
<iframe src="http://scidex.ai/artifact/wiki-diseases-european-neurodegeneration-epidemiology?embed=1" width="100%" height="600" style="border:0;border-radius:8px"></iframe>
[European Neurodegeneration Epidemiology](http://scidex.ai/artifact/wiki-diseases-european-neurodegeneration-epidemiology)
http://scidex.ai/artifact/wiki-diseases-european-neurodegeneration-epidemiology